Detalhe da pesquisa
1.
Mechanisms of response and resistance to combined decitabine and ipilimumab for advanced myeloid disease.
Blood
; 141(15): 1817-1830, 2023 04 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-36706355
2.
Molecular and cellular features of CTLA-4 blockade for relapsed myeloid malignancies after transplantation.
Blood
; 137(23): 3212-3217, 2021 06 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-33720354
3.
Durvalumab plus tremelimumab alone or in combination with low-dose or hypofractionated radiotherapy in metastatic non-small-cell lung cancer refractory to previous PD(L)-1 therapy: an open-label, multicentre, randomised, phase 2 trial.
Lancet Oncol
; 23(2): 279-291, 2022 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-35033226
4.
Immune determinants of CAR-T cell expansion in solid tumor patients receiving GD2 CAR-T cell therapy.
Cancer Cell
; 42(1): 35-51.e8, 2024 01 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-38134936
5.
Multi-omics Analysis Reveals Immune Features Associated with Immunotherapy Benefit in Patients with Squamous Cell Lung Cancer from Phase III Lung-MAP S1400I Trial.
Clin Cancer Res
; 30(8): 1655-1668, 2024 Apr 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-38277235
6.
Single-cell heterogeneity of EGFR and CDK4 co-amplification is linked to immune infiltration in glioblastoma.
Cell Rep
; 42(3): 112235, 2023 03 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-36920905
7.
Tutorial: integrative computational analysis of bulk RNA-sequencing data to characterize tumor immunity using RIMA.
Nat Protoc
; 18(8): 2404-2414, 2023 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-37391666
8.
FABP5 Inhibition against PTEN-Mutant Therapy Resistant Prostate Cancer.
Cancers (Basel)
; 16(1)2023 Dec 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-38201488
9.
Cross-Site Concordance Evaluation of Tumor DNA and RNA Sequencing Platforms for the CIMAC-CIDC Network.
Clin Cancer Res
; 27(18): 5049-5061, 2021 09 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-33323402